SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950005-97-000339
Filing Date
1997-03-27
Accepted
1997-03-27 00:00:00
Documents
13
Period of Report
1996-12-31
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 FORM 10-K405 10-K405 189514
2 EXHIBIT 3.1.1 EX-3.1.1 4204
3 EXHIBIT 3.4.1 EX-3.4.1 2800
4 EXHIBIT 3.5.1 EX-3.5.1 2773
5 EXHIBIT 3.6 EX-3.6 2714
6 STOCK PURCHASE AGREEMENT EX-10.25 31013
7 EXHIBIT 10.28 EX-10.28 21089
8 EXHIBIT 10.29 EX-10.29 58172
9 AGREEMENT OF MERGER EX-10.30 22492
10 EXHIBIT 10.31 EX-10.31 14419
11 EXHIBIT 21.1 EX-21.1 194
12 EXHIBIT 23.1 EX-23.1 588
13 FINANCIAL DATA SCHEDULE EX-27 5034
  Complete submission text file 0000950005-97-000339.txt   357530
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 74545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-22570 | Film No.: 97564388
SIC: 2833 Medicinal Chemicals & Botanical Products